Press Releases - 2023-06-05

Date	Title	Company
05-Jun-2023	GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI	Businesswire
05-Jun-2023	ZCG-Backed Unimed to Expand Operations into Singapore with Marine Pharma Merger	Businesswire
05-Jun-2023	At BIO 2023, Canada Showcases Multiple Strengths as a Biopharma Powerhouse	Businesswire
05-Jun-2023	Thermo Fisher Scientific Showcases Solutions for Accelerating Biological Discovery	Businesswire
05-Jun-2023	Charles River Laboratories to Present at William Blair and Jefferies Conferences	Businesswire
05-Jun-2023	Vaxxas Appoints Rochelle Chaiken, M.D., as Chief Medical Officer	Businesswire
05-Jun-2023	Gloves Market is Expected to Rise at a High CAGR of 9.4% by 2029 \| Exclusive Report by Data Bridge Market Research	The Wire Times
05-Jun-2023	Global CD137 Antibodies Clinical Trials Research Report 2023: Insights on More Than 60 CD137 Antibodies in Clinical Trials - ResearchAndMarkets.com	Businesswire
05-Jun-2023	Sarissa Urges Alkermes Shareholders to Vote the Universal Blue Card to Upgrade Alkermes for the Benefit of Shareholders	Businesswire
05-Jun-2023	Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™	Businesswire
05-Jun-2023	Coya Therapeutics Strengthens Scientific Advisory Board (SAB) with the Addition of Neuroimmunology Pioneer, Dr. Guillaume Dorothée, an Expert on the Role of the Immune System and Regulatory T Cells (Tregs) in Alzheimer’s Disease (AD)	Businesswire
05-Jun-2023	Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab	Businesswire
05-Jun-2023	Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)	Businesswire
05-Jun-2023	Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST™, the First and Only FDA-Approved Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection	Businesswire
05-Jun-2023	Precision BioSciences to Present at Upcoming June Investor Conferences	Businesswire
05-Jun-2023	Dental Sterilization Market to Observe Utmost CAGR 7.8% by 2030, Size, Share, Demand, Key Drivers, Development Trends and Competitive Outlook	The Wire Times
05-Jun-2023	KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Businesswire
05-Jun-2023	Medical Suction Devices Market Predicted to Grow at CAGR of 6.8% by 2031, AMR	The Wire Times
05-Jun-2023	Seneca Therapeutics, Inc. Appoints Cuong Do to its Board of Directors	Businesswire
05-Jun-2023	Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β Inhibitor, BCA101, Demonstrates 65% ORR in Combination with Pembrolizumab in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)	Businesswire